Business Update News

Stay updated with the latest business news. Read about company updates, strategic decisions, financial performance, and key developments in various industries. Discover insights that impact business operations and market trends.

Aug 28, 2025 at 8:28 PM

Gold Reserve Submits Improved Proposal in Citgo Sale Process

PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that, pursuant to the schedule set by the U.S. District Court for the District of Delaware (the “Court”), it submitted an improved proposal for the purchase of the shares of PDV Holding Inc. (“PDVH”), the indirect parent company of Citgo Petroleum. The terms of the Company’s improved proposal are confidential, per the bidding procedures, but the Company can...
Aug 28, 2025 at 5:06 PM

Cameco Provides Production Update; Strategically Well-Positioned for Continued Long-Term Value Creation

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) provided an operational update today regarding its 2025 production plans. Development delays in transitioning the McArthur River mine to new mining areas are expected to defer the extraction of pounds planned in 2025 and therefore impact our 2025 production forecast. However, strong performance at the Cigar Lake mine provides an opportunity to partially offset the deferred McArthur River production. We believe our balanced a...
Aug 28, 2025 at 4:15 PM

Aalo Atomics First to Break Ground as Part of President Trump’s Nuclear Reactor Pilot Program

AUSTIN, Texas & IDAHO FALLS, Idaho--(BUSINESS WIRE)--Today, Austin-based Aalo Atomics broke ground to start construction on Aalo-X, the first experimental extra modular nuclear reactor (XMR). Located next to Idaho National Laboratory (INL)’s Materials and Fuels Complex, Aalo plans to complete construction and achieve criticality for this reactor by July 4th, 2026. The groundbreaking event – coming just two weeks after Aalo was selected by the U.S. Department of Energy (DOE) to participate in Pr...
Aug 28, 2025 at 3:49 PM

Jimmy John’s Opens in Niagara Falls, Its Second Location in Canada, With 12 More Scheduled to Open by Year’s End

MONTREAL--(BUSINESS WIRE)--Jimmy John’s, the delicious, freaky fast sandwich maker known for its obsession with pickles, opened its second location in Canada yesterday at Fallsview Casino in Niagara Falls. The opening is part of a wave of new stores – 12 according to the last count – that will open across Canada by year's end. New stores are expected to open in Winnipeg, Ottawa, Edmonton, Barrie, Windsor, and additional locations in the Greater Toronto Area. “We have a big appetite for opening...
Aug 28, 2025 at 3:43 PM

KEO World Inc. announces Business Combination of its Global Trade Card (GTC) program with MAHA Capital

MIAMI & STOCKHOLM--(BUSINESS WIRE)--KEO World Inc., a lending fintech infrastructure platform for embedded credit B2B payments, today officially entered into a binding agreement to combine its GTC business with MAHA Capital AB, a publicly listed investment company on Nasdaq Stockholm. This transaction is designed to significantly strengthen our financial foundation and accelerate our global expansion. MAHA brings over USD 120 million in cash and liquid assets, while Keo investors will contribut...
Aug 28, 2025 at 3:00 PM

A.M. Best Reaffirms Grange Insurance’s “A” (Excellent) Rating and Stable Outlook

COLUMBUS, Ohio--(BUSINESS WIRE)--Grange Insurance Company and its affiliate Integrity Insurance Company continue to be financially strong and stable, according to A.M. Best, a global credit rating agency that specializes in the insurance industry. A.M. Best reaffirmed Grange Insurance and Integrity Insurance’s financial strength rating (FSR) of “A” (Excellent) and its stable outlook for all its property and casualty companies. The FSR is the most crucial component of A.M. Best’s rating as it in...
Aug 28, 2025 at 2:00 PM

GenSight Biologics Postpones Release of 2025 Half-Year Financial Results

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the release of its half-year financial results, originally scheduled for September 19, 2025, has been postponed to September 29, 2025, after the market clos...
Aug 28, 2025 at 2:00 PM

World Chess Hall of Fame & Galleries Announces New Exhibition: Reading Between the Lines: Chess & Literature

ST. LOUIS--(BUSINESS WIRE)--The World Chess Hall of Fame & Galleries (WCHOF), the leading chess cultural center in the country, is proud to announce the upcoming opening of its newest exhibition, Reading Between the Lines: Chess & Literature, which explores the powerful role chess has played in shaping stories of adventure, morality, imagination, and struggle across centuries. Featuring rare books, artwork, artifacts and literary-themed chess sets from the 18th century to the present, t...
Aug 28, 2025 at 12:56 PM

Decatur Plastic Products, Rebranded as Elton USA, Expands Auto Parts Capacity Following Capital Infusion

NORTH VERNON, Ind.--(BUSINESS WIRE)--Decatur Plastic Products (DPP), a long-standing American automotive injection molding company, has repositioned for accelerated growth after receiving significant capital investment from veteran Canadian manufacturer, Elton Manufacturing. Under new ownership, DPP has been officially integrated and rebranded as “Elton USA”. Since the transition, production has surged, reflecting enhanced operational capacity and a renewed strategic focus. Following a fire in...
Aug 28, 2025 at 12:51 PM

ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 2nd Quarter 2025

TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural recombinant apoA-I, today provides an update on its activity and cash position as of June 30, 2025. The activity dedicated to the discovery and development of innovative therapies, particularly in sepsis or the rare disease, LCAT deficien...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up